Delivery Order SPE2DB22D1017-SPE2DB25FYQUF
- Not listed
- The Defense Logistics Agency awarded a $1,278.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of CAPLYTA 42 mg capsules (30-count units). AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was selected through competitive procurement with no set-aside designation. The delivery order has an ultimate completion date of July 23, 2025, with performance at the contractor's Conshohocken...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of CAPLYTA 42 mg capsules (30-count units) with a ceiling value of $4,686.46. This firm fixed-price delivery order, awarded on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a non-competitive set-aside contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $13,827.40 to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of CAPLYTA 42 MG capsules (30-count units). The contract utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award to this established pharmaceutical distributor. Performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania location, with completion scheduled for September 9, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,236.39 to AmerisourceBergen Drug Corp for CAPLYTA 42 mg capsules (30-count units) on July 30, 2025, with an ultimate completion date of July 31, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. CAPLYTA is a pharmaceutical treatment for psychiatric conditions, reflecting the company's...
- On July 29, 2025, the Defense Logistics Agency awarded a delivery order valued at $7,172.24 to AmerisourceBergen Drug Corp for CAPLYTA 42 mg capsules (30-count units). This firm fixed price delivery order, with an ultimate completion date of July 30, 2025, represents a non-set-aside competitive award supporting federal medical procurement. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company operates as a major pharmaceutical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 16, 2025, for the supply of CAPLYTA 42 mg capsules in a quantity of 30 units. This firm fixed price delivery order, valued at $29,358.50 with an ultimate completion date of September 17, 2025, represents a non-set-aside competitive award. The contract will be performed at the awardee's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for CAPLYTA 10.5 mg capsules (30-count units) valued at $37,624.77 on June 26, 2025, with completion scheduled for June 27, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. The contract requires...
- The Defense Logistics Agency awarded a delivery order valued at $12,137.10 to AmerisourceBergen Drug Corp for the supply of CAPLYTA 21 mg capsules (30-count units). This firm fixed-price delivery order, which carries no set-aside designation, was competitively awarded and is set for completion by August 4, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary distribution operations....
- The Defense Logistics Agency awarded a delivery order valued at $43,416.77 to AmerisourceBergen Drug Corp for the supply of CAPLYTA 42 mg capsules (30-count units) on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract reflects no set-aside designation and specifies Conshohocken, Pennsylvania as the place of performance, aligning with AmerisourceBergen's corporate headquarters location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $10,244.42 to AmerisourceBergen Drug Corp for the supply of CAPLYTA 42 mg capsules (30-count units). The contract, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, utilizes firm fixed-price pricing and carries no set-aside designation, indicating it was competitively awarded. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYQUFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of CAPLYTA 42 mg capsules (30-count units) under a firm fixed-price contract with a ceiling value of $5,766.76. This non-set-aside award was issued on September 15, 2025, with an ultimate completion date of September 16, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location in the same city. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. AmerisourceBergen Drug Corp's status as a prime vendor reflects its capability to meet competitive federal procurement requirements and support critical medical supply needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.8k | 9/15/25 |